Glutathione Market Analysis

Glutathione Market Analysis

Reduced glutathione market size should surpass USD 200 million by 2027 and is anticipated to show growth over 7.0% CAGR up to 2027. There is a continuous rise in the cancer cases around the globe, which is the second leading cause of death globally. According to World Health Organization, in 2020 cancer was responsible for 9.6 million deaths. There are several factors responsible for rising cancer prevalence such as population growth, change in lifestyle, increasing number of smokers, and tobacco use. Therefore, rising cancer burden around the globe should propel the growth for reduced glutathione, owing to its suitability to prevent harmful side effects of chemotherapy to cancer patients.
 

The demand for manufacturing drugs in the region in high, owing to the presence of several pharmaceutical manufacturers including Johnson and Pfizer & Johnson. Hence, wide presence of pharmaceutical manufacturers in the region generates huge opportunity for glutathione market as the product is highly utilized in the manufacture of many pharmaceutical products.  North America led by U.S. is predicted register over 7% gains at the end of 2027. The growth is attributed to several benefits associated with the product such as tissue repairing & building and immune system boosting. The product is also utilized for treating numerous diseases which include asthma, cataract, and anemia.